Aqua Bio Technology ASA (OSL:ABTEC)
Norway · Delayed Price · Currency is NOK 4.220
-0.300 (-6.64%)
At close: Aug 4, 2026
Aqua Bio Technology ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.66 | 6 | 4.84 | 1.86 | 13.36 |
Short-Term Investments | - | - | 0.18 | 0 | - |
Cash & Short-Term Investments | 2.66 | 6 | 5.02 | 1.86 | 13.36 |
Cash Growth | -55.71% | 19.58% | 169.61% | -86.06% | 146.01% |
Accounts Receivable | 0.62 | 7.26 | 18.17 | 2.6 | 2.81 |
Inventory | 0 | 5.52 | 23.88 | 8.3 | 5.69 |
Other Current Assets | 0 | 0.44 | 1.76 | 0 | - |
Total Current Assets | 3.28 | 19.22 | 48.84 | 12.77 | 21.86 |
Net Property, Plant & Equipment | 0.04 | 18.88 | 17.15 | 0.27 | 0.29 |
Other Intangible Assets | 0 | 9.78 | 41.12 | 19.48 | 12.28 |
Goodwill | 0 | 0 | 123.47 | 34.69 | - |
Long-Term Investments | 126.7 | 127.45 | - | - | - |
Other Long-Term Assets | 0 | 0.07 | 7.16 | 0 | 0 |
Total Assets | 130.02 | 175.4 | 237.74 | 67.2 | 34.43 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 11.52 | 78.47 | 67.08 | 7.07 | 4.76 |
Accrued Expenses | 0 | 0 | 0 | 0.01 | 0 |
Current Portion of Long-Term Debt | 108.77 | 102.7 | 22.84 | 15.89 | 7.12 |
Current Portion of Leases | 0 | 7.1 | 5.64 | 0.34 | 0 |
Other Current Liabilities | 9.27 | 4.98 | 23.95 | 1.51 | 0.18 |
Total Current Liabilities | 129.56 | 193.25 | 119.51 | 24.82 | 12.06 |
Long-Term Debt | 0 | 47.7 | 9.34 | 0 | - |
Long-Term Leases | 0 | 28.97 | 14.9 | 0.67 | 0 |
Other Long-Term Liabilities | 0.95 | 13.25 | 8.22 | 39.85 | 3.67 |
Total Long-Term Liabilities | 0.95 | 89.92 | 32.46 | 40.52 | 3.67 |
Total Liabilities | 130.51 | 283.17 | 151.97 | 65.34 | 15.72 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 16.14 | 272.13 | 118.54 | 51.68 | 51.56 |
Treasury Stock | -0.65 | -0.03 | -0.03 | -0.03 | -0.03 |
Additional Paid-in Capital | 31.21 | 10.56 | 41.95 | 3.88 | - |
Retained Earnings | -47.19 | -390.42 | -74.69 | -53.67 | -32.82 |
Shareholders' Equity | -0.49 | -107.77 | 85.78 | 1.86 | 18.71 |
Total Liabilities & Equity | 130.02 | 175.4 | 237.74 | 67.2 | 34.43 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 108.77 | 186.47 | 52.71 | 16.91 | 7.12 |
Net Cash (Debt) | -106.11 | -180.46 | -47.69 | -15.04 | 6.23 |
Net Cash Growth | - | - | - | - | 44.17% |
Net Cash Per Share | -41.92 | -132.60 | -78.08 | -36.29 | 16.22 |
Book Value | -0.49 | -107.77 | 85.78 | 1.86 | 18.71 |
Book Value Per Share | -0.19 | -79.18 | 140.43 | 4.49 | 48.68 |
Tangible Book Value | -0.49 | -117.55 | -78.81 | -52.31 | 6.42 |
Tangible Book Value Per Share | -0.19 | -86.37 | -129.03 | -126.17 | 16.71 |